An interferon-free, ribavirin-free 12-week regimen of daclatasvir (DCV), asunaprevir (ASV), and BMS-791325 yielded SVR4 of 94% in treatment-naive patients with genotype (GT) 1 chronic hepatitis C virus (HCV) infection

Authors
Category Primary study
ConferenceHepatology
Year 2012
This article has no abstract
Epistemonikos ID: 8906a7ee766449c5ef2fb8f5cd80f22ab198883d
First added on: Apr 30, 2026